LAUREN DAVIS: Open Payments
NPI 1114521366 · NACOGDOCHES, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,081 in 61 payments from 12 companies in 2025. Trend: 2023 $937 · 2024 $910 · 2025 $1,081
Food & beverage: $991Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $393 |
| UCB, Inc. | 14 | $171 |
| Novartis Pharmaceuticals Corporation | 7 | $126 |
| GENZYME CORPORATION | 5 | $124 |
| ABBVIE INC. | 5 | $80 |
| Lilly USA, LLC | 3 | $53 |
| Amgen Inc. | 3 | $53 |
| BioWound Solutions, Inc. | 1 | $23 |
| Biofrontera Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: TREMFYA, Bimzelx, DUPIXENT, COSENTYX, TALTZ, OTEZLA, RINVOQ, Rhapsido.
Industry payments across TX — which companies pay providers there.
